vs

Side-by-side financial comparison of Teradyne (TER) and Xylem Inc. (XYL). Click either name above to swap in a different company.

Xylem Inc. is the larger business by last-quarter revenue ($2.1B vs $1.3B, roughly 1.7× Teradyne). Teradyne runs the higher net margin — 31.1% vs 8.9%, a 22.2% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 2.7%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs -1.0%).

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.

TER vs XYL — Head-to-Head

Bigger by revenue
XYL
XYL
1.7× larger
XYL
$2.1B
$1.3B
TER
Growing faster (revenue YoY)
TER
TER
+84.3% gap
TER
87.0%
2.7%
XYL
Higher net margin
TER
TER
22.2% more per $
TER
31.1%
8.9%
XYL
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
32.6%
-1.0%
XYL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
TER
TER
XYL
XYL
Revenue
$1.3B
$2.1B
Net Profit
$398.9M
$189.0M
Gross Margin
60.9%
37.8%
Operating Margin
36.9%
11.5%
Net Margin
31.1%
8.9%
Revenue YoY
87.0%
2.7%
Net Profit YoY
100.0%
EPS (diluted)
$2.53
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TER
TER
XYL
XYL
Q1 26
$1.3B
$2.1B
Q4 25
$1.1B
$2.4B
Q3 25
$769.2M
$2.3B
Q2 25
$651.8M
$2.3B
Q1 25
$685.7M
$2.1B
Q4 24
$752.9M
$2.3B
Q3 24
$737.3M
$2.1B
Q2 24
$729.9M
$2.2B
Net Profit
TER
TER
XYL
XYL
Q1 26
$398.9M
$189.0M
Q4 25
$257.2M
$335.0M
Q3 25
$119.6M
$227.0M
Q2 25
$78.4M
$226.0M
Q1 25
$98.9M
$169.0M
Q4 24
$146.3M
$326.0M
Q3 24
$145.6M
$217.0M
Q2 24
$186.3M
$194.0M
Gross Margin
TER
TER
XYL
XYL
Q1 26
60.9%
37.8%
Q4 25
57.2%
38.9%
Q3 25
58.4%
38.9%
Q2 25
57.2%
38.8%
Q1 25
60.6%
37.1%
Q4 24
59.4%
38.0%
Q3 24
59.2%
37.3%
Q2 24
58.3%
37.8%
Operating Margin
TER
TER
XYL
XYL
Q1 26
36.9%
11.5%
Q4 25
27.1%
14.7%
Q3 25
18.9%
14.7%
Q2 25
13.9%
13.3%
Q1 25
17.6%
11.2%
Q4 24
20.4%
11.8%
Q3 24
20.6%
13.3%
Q2 24
28.8%
11.7%
Net Margin
TER
TER
XYL
XYL
Q1 26
31.1%
8.9%
Q4 25
23.7%
14.0%
Q3 25
15.5%
10.0%
Q2 25
12.0%
9.8%
Q1 25
14.4%
8.2%
Q4 24
19.4%
14.5%
Q3 24
19.8%
10.3%
Q2 24
25.5%
8.9%
EPS (diluted)
TER
TER
XYL
XYL
Q1 26
$2.53
$0.79
Q4 25
$1.62
$1.37
Q3 25
$0.75
$0.93
Q2 25
$0.49
$0.93
Q1 25
$0.61
$0.69
Q4 24
$0.89
$1.33
Q3 24
$0.89
$0.89
Q2 24
$1.14
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TER
TER
XYL
XYL
Cash + ST InvestmentsLiquidity on hand
$241.9M
$808.0M
Total DebtLower is stronger
$0
$1.9B
Stockholders' EquityBook value
$11.0B
Total Assets
$4.4B
$17.0B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TER
TER
XYL
XYL
Q1 26
$241.9M
$808.0M
Q4 25
$293.8M
$1.5B
Q3 25
$272.7M
$1.2B
Q2 25
$339.3M
$1.2B
Q1 25
$475.6M
$1.1B
Q4 24
$553.4M
$1.1B
Q3 24
$510.0M
$989.0M
Q2 24
$421.9M
$815.0M
Total Debt
TER
TER
XYL
XYL
Q1 26
$0
$1.9B
Q4 25
$2.0B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
Q2 24
Stockholders' Equity
TER
TER
XYL
XYL
Q1 26
$11.0B
Q4 25
$2.8B
$11.5B
Q3 25
$2.7B
$11.2B
Q2 25
$2.8B
$11.1B
Q1 25
$2.8B
$10.8B
Q4 24
$2.8B
$10.6B
Q3 24
$2.9B
$10.6B
Q2 24
$2.7B
$10.3B
Total Assets
TER
TER
XYL
XYL
Q1 26
$4.4B
$17.0B
Q4 25
$4.2B
$17.6B
Q3 25
$4.0B
$17.3B
Q2 25
$3.8B
$17.2B
Q1 25
$3.7B
$16.6B
Q4 24
$3.7B
$16.5B
Q3 24
$3.8B
$16.0B
Q2 24
$3.6B
$15.8B
Debt / Equity
TER
TER
XYL
XYL
Q1 26
0.18×
Q4 25
0.17×
Q3 25
0.18×
Q2 25
0.18×
Q1 25
0.19×
Q4 24
0.19×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TER
TER
XYL
XYL
Operating Cash FlowLast quarter
$265.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
0.66×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TER
TER
XYL
XYL
Q1 26
$265.1M
Q4 25
$281.6M
$543.0M
Q3 25
$49.0M
$360.0M
Q2 25
$182.1M
$305.0M
Q1 25
$161.6M
$33.0M
Q4 24
$282.6M
$575.0M
Q3 24
$166.3M
$311.0M
Q2 24
$216.1M
$288.0M
Free Cash Flow
TER
TER
XYL
XYL
Q1 26
Q4 25
$218.8M
$460.0M
Q3 25
$2.4M
$281.0M
Q2 25
$131.7M
$207.0M
Q1 25
$97.6M
$-38.0M
Q4 24
$225.2M
$475.0M
Q3 24
$114.4M
$237.0M
Q2 24
$171.2M
$215.0M
FCF Margin
TER
TER
XYL
XYL
Q1 26
Q4 25
20.2%
19.2%
Q3 25
0.3%
12.4%
Q2 25
20.2%
9.0%
Q1 25
14.2%
-1.8%
Q4 24
29.9%
21.1%
Q3 24
15.5%
11.3%
Q2 24
23.5%
9.9%
Capex Intensity
TER
TER
XYL
XYL
Q1 26
4.2%
Q4 25
5.8%
3.5%
Q3 25
6.1%
3.5%
Q2 25
7.7%
4.3%
Q1 25
9.3%
3.4%
Q4 24
7.6%
4.4%
Q3 24
7.0%
3.5%
Q2 24
6.1%
3.4%
Cash Conversion
TER
TER
XYL
XYL
Q1 26
0.66×
Q4 25
1.09×
1.62×
Q3 25
0.41×
1.59×
Q2 25
2.32×
1.35×
Q1 25
1.63×
0.20×
Q4 24
1.93×
1.76×
Q3 24
1.14×
1.43×
Q2 24
1.16×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TER
TER

Segment breakdown not available.

XYL
XYL

Revenue from products$1.8B83%
Revenue from services$368.0M17%

Related Comparisons